Hypoxia-inducible factor-1α activation improves renal oxygenation and mitochondrial function in early chronic kidney disease
- 1 August 2017
- journal article
- Published by American Physiological Society in American Journal of Physiology-Renal Physiology
- Vol. 313 (2) , F282-F290
Abstract
The pathophysiology of chronic kidney disease (CKD) is driven by alterations in surviving nephrons to sustain renal function with ongoing nephron loss. Oxygen supply-demand mismatch, due to hemodynamic adaptations, with resultant hypoxia, plays an important role in the pathophysiology in early CKD. We sought to investigate the underlying mechanisms of this mismatch. We utilized the subtotal nephrectomy (STN) model of CKD to investigate the alterations in renal oxygenation linked to sodium (Na) transport and mitochondrial function in the surviving nephrons. Oxygen delivery was significantly reduced in STN kidneys because of lower renal blood flow. Fractional oxygen extraction was significantly higher in STN. Tubular Na reabsorption was significantly lower per mole of oxygen consumed in STN. We hypothesized that decreased mitochondrial bioenergetic capacity may account for this and uncovered significant mitochondrial dysfunction in the early STN kidney: higher oxidative metabolism without an attendant increase in ATP levels, elevated superoxide levels, and alterations in mitochondrial morphology. We further investigated the effect of activation of hypoxia-inducible factor-1α (HIF-1α), a master regulator of cellular hypoxia response. We observed significant improvement in renal blood flow, glomerular filtration rate, and tubular Na reabsorption per mole of oxygen consumed with HIF-1α activation. Importantly, HIF-1α activation significantly lowered mitochondrial oxygen consumption and superoxide production and increased mitochondrial volume density. In conclusion, we report significant impairment of renal oxygenation and mitochondrial function at the early stages of CKD and demonstrate the beneficial role of HIF-1α activation on renal function and metabolism.Keywords
Funding Information
- U.S. Department of Veterans Affairs (VA) (BX002175, BX001963)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (DK107852, DK101841, P30-DK 079337)
- HHS | NIH | National Heart, Lung, and Blood Institute (NHBLI) (HL091071, HL107200, HL066941)
- HHS | NIH | National Institute of General Medical Sciences (NIGMS) (P41GM103412-28)
This publication has 59 references indexed in Scilit:
- AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial functionJournal of Clinical Investigation, 2013
- Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasisProceedings of the National Academy of Sciences, 2012
- During autophagy mitochondria elongate, are spared from degradation and sustain cell viabilityNature Cell Biology, 2011
- Assessing mitochondrial dysfunction in cellsBiochemical Journal, 2011
- Hypoxia. 2. Hypoxia regulates cellular metabolismAmerican Journal of Physiology-Cell Physiology, 2011
- Renal protection in chronic kidney disease: hypoxia-inducible factor activation vs. angiotensin II blockadeAmerican Journal of Physiology-Renal Physiology, 2010
- Mitochondria and Reactive Oxygen SpeciesHypertension, 2009
- Unexpected effect of angiotensin AT1receptor blockade on tubuloglomerular feedback in early subtotal nephrectomyAmerican Journal of Physiology-Renal Physiology, 2009
- Regulation of oxygen utilization by angiotensin II in chronic kidney diseaseKidney International, 2009
- Mitochondrial Autophagy Is an HIF-1-dependent Adaptive Metabolic Response to HypoxiaJournal of Biological Chemistry, 2008